Frontier Medicines is a biopharmaceutical company focused on developing precision medicines targeting previously undruggable disease-causing proteins. Leveraging their proprietary Frontier™ and AutoTAC™ platforms, which integrate chemoproteomics, covalent chemistry, and machine learning, the company aims to create breakthrough therapies for genetically-defined patient populations.
Founded: 2018
Chris Varma Co-Founder, CEO, Chairman |
Andrew Krivoshik Chief Medical Officer |
Johannes Hermann CTO |
Kevin Webster Chief Scientific Officer |
Monique Bobadilla Chief People and Culture Officer |